Tomio Takeuchi
Institute of Microbial Chemistry, 3-14-23 Kamiosaki, Tokyo 141, Japan (Received for publication August 23, 1991) 7-O-[2,6-Dideoxy-2-fluoro-4-O-(3-fluorotetrahydropyran-2-yl)-a-L-talopyranosyl]daunomycinones (7a~7c) have been prepared by condensation of 3'-0-benzoyl derivative of 7-0-(2,6-dideoxy-2-fluoro-a-L-talopyranosyl)daunomycinone with 2,3-difluorotetrahydropyran as the key reaction. Antitumor activities of these compounds are described.
Recently we reported the synthesis and antitumor activities of 7-<9-(2,6-dideoxy-2-fluoro-a-Ltalopyranosyl)daunomycinone
(1) and -adriamycinone1'2) (2) together with their analogs.3~5) Most of them showed higher antitumor activities than doxorubicin and daunorubicin, and showed muchlower toxicity. Characteristic features of these compoundsin terms of chemical structure are that someof them have no amino group at C-3',1~3>5) which has been believed to be essential for activity, and most of the compounds have a C-2' fluorine,1~4) no functional group being attached here in the usual anthracycline antitumor antibiotics. On the other hand, structurally related aclacinomycins6'7) and (2"R)A '-0-tetrahydropyranyladriamycin,8'9) have a 4'-0-giycosyl moiety and exhibit lower toxicity with higher antitumor activity1°'1 1) than doxorubicin. Further, the last compound was reported12) to be readily taken up by tumor cells. With all of these facts in mind, we have undertaken to prepare several 4'-O-glycosyl derivatives of 1 and 2. This paper describes the synthesis and antitumor activity of 4'-0-(3-fluorotetrahydropyran-2-yl) derivatives (7) of 1. As these compounds 7 have a tetrahydropyranyl moiety bearing a fluorine at the vicinal position to the glycosyl bond, the moiety would be expected to resist acid-catalyzed hydrolysis due to the strong electron-withdrawing property of the vicinal fluorine; in the cases of aclacinomycins and 4'-O-tetrahydropyranyl derivatives, the 4'-O-glycosyl group is readily cleaved chemically. Weundertook the preparation of 7 to test whether the enhanced chemical stability would also be retained in in vivo experiments.
Treatment of 1 with benzoyl chloride in dichloromethane -pyridine gave selectively the 3'-0-benzoyl derivative (3) with the axial 4'-OH remained free. Next, in order to introduce 3-fluorotetrahydropyran-2-yl group at the 4'-OH, 2,3-difluorotetrahydropyran was first prepared. Introduction of fluorine gas into 3,4-dihydro-2//-pyran in cold (-78°C) dichloromethane readily gave the difluoro derivatives (4 and 5); however, these products were markedly unstable in an acidic medium(in this case, HF was formed inevitably), and decomposed on concentration, so that they could not be isolated in a pure state. Therefore, the above reaction mixture was immediately coupled with 3 in the presence ofAgClO4, SnCl2, and molecular MAR. 1992 tetrahydropyran, however, could be proved by the *H and 19F NMRspectra on the sample prepared as follows: After treatment of 3,4-dihydro-2i/-pyran with F2 in argon in cold (-78°C) dichloromethaned2, the solution was washed thoroughly with cold aqueous sodium thiosulfate, and, without delay, the XH and 19F NMRspectra were measured; the 19F spectrum showed clear signals (Table 1) for cis (4) and trans 2,3-difluoroterahydropyran (5) in a 7.5 : 2.5 ratio. The coupling constants indicate (based on the reported coupling constants13) for 2-fluoroglycopyranosyl fluorides) that both 4 and 5 have a chair conformation, respectively, having 2-axial-3-equatorial (for 4) and 2,3-diaxial fluorines (for 5). It was surprising that these fundamental substances 4 and 5 have not been reported previously.
Debenzoylation of 6 with methanolic sodium hydroxide gave the three final products (7a, 7b, and 7c). Separation of them was, however, tedious and performed only by repeated column chromatography and HPLCto give pure products in 31.4 (7a), 6.4 (7b), and 20.1 %(7c), respectively. The structures of the products were determined from their NMRspectra (XH, 19F, and 13C (Table 2)) to be the expected 4'-0-(3-fluorotetrahydropyran-2-yl) derivatives of 1, but the absolute configurations at C-2" and C-3" remained undetermined. However, judging from the 1H and 19F NMRdata as shown in Table 3 (in some signal-regions assignments are difficult due to bad signal dissolution or overlapping), the structures could partly be clarified. First, compound 7b is determined to be a 2",3"-ds product (the large JyA"a value, and narrow signal-range of one wing of the broad 3"-F doublet suggest the equatorial 3"-F, and the small J2»t3" value suggests the axial 2"-OR) with a chair conformation of 2"C5,, (3"S) (C) or 5"C2-» (3"R) (C) (see Fig. 2 ). Compound7a was concluded to have a T,3"-trans structure with 3"S or 3"R as a mixture of two chair conformations (A and B, or D and E) (judged from relatively large JT\y value (6Hz) and relatively large signal-range of one wing of the broad 3"-F doublet (Table 3) ). It should be stressed here that the observed coupling (/= 6 Hz) between 3 -O# and 3"-F is considered to be a through-space coupling. This indicates that both atoms come close to each other, suggesting the contribution of the Aconformation of 7a (see later in detail). Compound 7c will be a 2",3"-trans product, judging from the similarity of the signal pattern with that for 7a and therefore, it will be an enantiomer of 7a in terms of its 3-fluorotetrahydropyranyl portion, and the conformation will be a mixture of D and E, or A and B. -Shifts of 2"-H for 7a, 7b, and 7c also support the above conclusions, that is, 2"-H of 7b is the most deshielded (Table 3) , whereas the 2"-H's of7a and 7c are comparatively shielded suggesting the involvement of the axial 2"-H. Slightly deformed dddd.
Although, as described above, absolute con figurations of the 3-flurotetrahydropyranyl portion at C-2" and C-3" of 7a, 7b, and 7c remained undetermined, the large difference in optical rotations among them (Table 3) This phenomenonoriginates from the difference in electron-density around the anomeric center. If such an experimental rule is applied to our cases (although the G-6" substituents of 7a~7c are two hydrogens, there will be little difference from the alkyl substituent in I~IV in terms of the contribution to the rotations), the following assignments will be made. As the contribution of the 3-flurotetrahydropyranyl portion of 7b to its rotation is R = [7-O-(2,6-Dideoxy-2-fluoro-a-L-talopyranosyl)-daunomycinone] -4'-yl expected to be highly negative, structure C (resembles IV), rather than C is assigned. Compound7a has the highest rotational value, and therefore it should be a mixture of A and B (resembles II and I) rather than that of D and E (resembles IV and III) and 7c, vice versa. In conclusion, we decided that the structures of7a, 7b, and 7c are as shown in Fig. 1 .
Antitumor activities of 7a, 7b, and 7c were measured (Tables 4 and 5 ) and it was concluded that the three compounds and 1 have similar activity. However,as the three compounds were non-toxic in the amount of 100/ig/mouse/day (Table 5) , this derivation will give less toxic derivatives compared to the parent anthracycline antibiotics.
Other biological characteristics will be reported in the future with other related compounds.
Experimental
Optical rotations were measured with a Perkin-Elmer 241 polarimeter. TLCwas carried out on precoated Kieselgel 60 F254 (Merck). Column chromatography was performed on Wakogel C-200. HPLC was performed with a SSC-6200 instrument (Senshu Scientific Co.) with a UVdetector (SSC 3000A-II) set at 290nm. NMRspectra (XH at 250MHz, 19F at 235.3MHz, and 13C at 62.9MHz ) were recorded with a Bruker WM250 spectrometer. Chemical shifts (<5) are reported down field from internal tetramethylsilane or Freon 1 1 (CFC13; for 19F). (trace). Methanol (10^1) and then CHC13 (20ml) were added and the solution was washed successively with 20% aqKHSO4, saturated aqNaHCO3, and water, dried (Na2SO4), and concentrated. The residue was separated by silica gel column chromatography with CHC13-Me2CO (12: 1) to give 3 as a reddish-orange solid, 78 mg (90% a IC50 values were determined on day-3 culture.
b Resistant factor (RF): IC50 for resistant subline against IC50 for sensitive subline. Leukemia L1210 cells (105) were inoculated into CDFi mice (20+l g) intraperitoneally.
Drugs were administered daily, starting 24 hours after inoculation, from day-1 to -9, intraperitoneally. * Toxic. Preparation of DL-2,3-m-2,3-Difluorotetrahydropyran (4) and DL-2,3-trans-2,3-DiMorotetvahydropyran (5) in CD2C12
To a cold (-78°C) solution of 3,4-dihydro-2//-pyran (50mg) in CD2C12(2ml, dried over molecular sieves 4A) was introduced fluorine (600 ml of 5% F2 in argon) by gentle bubbling for 30 minutes. Nitrogen was then bubbled for a while at the temperature to removea part of excess fluorine remained. The resulting solution, which is strongly acidic when examined by pH-test paper, was thoroughly washed with ice-cold aqueous Na2S2O3(5 ml x 6; washing should be done until the clear aqueous layer was resulted, the turbidity being caused by the sulfur liberated by the reaction between F2 and this reagent; insufficient washing caused decomposition of the products during storage), aqueous saturated NaHCO3, aqueous saturated NaCl, and finally with D2O, and dried over MgSO4. The solution was directly measured by NMR A stream of 5%F2 in argon (1.6 liters) was introduced into a solution of 3,4-dihydro-2//-pyran (0.2 g) in dry dichloromethane (4ml) by gentle bubbling at -78°C for 1 hour. A portion of the resulting solution (2.2ml) was added immediately to an ice-cold suspension of3 (166mg), AgClO4 (116mg), SnCl2 (97mg), and powdered molecular sieves 4A (830mg) in dry dichloromethane (3.3 ml), and the mixture was stirred vigorously at 0°C for 4 hours. The supernatant layer showed, on TLC with CHC13-Me2CO(30 : 1), spots at Rf 0.3 (slight), 0.23 (major, 6), 0.17 (slight), and 0.1 (minor, 3). The reaction mixture was filtered with aid of Celite and the mass was washed thoroughly with CHC13.The combined filtrates were washed successively with saturated aqNaHCO3 and water, dried (Na2SO4), and concentrated. The residue was chromatographed on a column of silica gel with CHC13-Me2CO (30: 1) to give a red solid of 6 as a mixture of three diastereomers (1 :2.6 : 3.1, judged by 19F NMR), 152mg (79%). An analytical sample was prepared by reprecipitation from CHC13-hexane. *H NMR(CDC13) 5 1.36, 1.42, and 1.47 (3H in total, each d, /5%6,=6.5Hz, 5'-Me), 2.43 (3H, s, 13-Me), 4.07 and 4.08 (3H in toral, each s, OMe), 13.26 and 13.27 (1H in total, each s, ll-or 6-OH), 14.01, 14.03, and 14.04 (1H in total, each s, 6-or ll-OH); To an ice-cold solution of 6 (196mg) in oxolane-MeOH (1 : 1, 20ml) was added 0.4m methanolic NaOH(10ml) and the mixture was stirred at 0°C for 1 hour. The resulting deep-purple solution showed, on TLC with CHC13-Me2CO(15 : 1), spots at Rf0.13 (7a) and 0.19 (7b and 7c). After gradual neutralization
